Arasali, Altina .

HRN: 28-64-09  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2026
CEFUROXIME 500MG (TAB)
03/02/2026
03/09/2026
PO
500mg
BID
Thickly Msaf
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines